メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
第2・外科
病院局
ばんたね病院
概要
フィンガープリント
ネットワーク
研究成果
(101)
フィンガープリント
第2・外科が活動している研究トピックを掘り下げます。これらのトピックラベルは、この組織のメンバーの研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Medicine and Dentistry
Neoplasm
100%
Recurrent Disease
83%
Lymph Node Metastasis
55%
Rectum Cancer
51%
Breast Cancer
46%
Surgery
44%
Colon
41%
Metastatic Carcinoma
37%
Colorectal Cancer
33%
Carcinoid
31%
Aromatase
31%
Chemoradiotherapy
31%
Anal Canal
31%
Exon
30%
Adenocarcinoma
28%
Breast Carcinoma
27%
Local Excision
26%
Sigmoid
24%
Retroperitoneal Lymph Node Dissection
21%
Bleeding
21%
Liver Metastasis
20%
Inguinal Lymph Node
20%
Colon Cancer
20%
Malignant Neoplasm
20%
Invagination
17%
Stoma
17%
Fluorouracil
17%
Radiation Therapy
17%
Adjuvant Chemotherapy
16%
Surgical Anastomosis
15%
Breast Tissue
15%
Tamoxifen
14%
Aromatase Inhibitor
14%
Lymph Node
14%
Sigmoid Cancer
13%
Prolapse
13%
Superior Mesenteric Artery
13%
Infection
12%
Infusion
12%
Cancer Cell
12%
Operation Duration
12%
Lower Anterior Resection
12%
Artery
12%
Survival Rate
11%
Colonoscopy
10%
Surgical Margin
10%
Aneurysm
10%
Immunoglobulin M
10%
Male Sexual Function
10%
Infusion Therapy
10%
Early Cancer
10%
Tumor Necrosis Factor
10%
Necrosis
10%
Polypectomy
10%
Cyclin D1
10%
Diethylstilbestrol
10%
Biloma
10%
Hormone Therapy
10%
Breast Disease
10%
Arterial Embolization
10%
Colorectal Anastomosis
10%
Intraarterial Drug Administration
10%
Mucinous Carcinoma
10%
Cancer Recurrence
10%
Blood Group
10%
Drug Megadose
10%
Central Vein
10%
Intestinal Bleeding
10%
Quality of Life
10%
Colon Tumor
10%
Hepatic Arterial Infusion
10%
Phyllodes Tumor
10%
Breast Surgery
10%
Steroid Sulfatase
10%
Transverse Colon
10%
Androstane Derivative
10%
Everolimus
10%
Internal Iliac Artery
10%
Sentinel Node
10%
Cancer Radiotherapy
10%
Colostomy
10%
Pathophysiology
10%
Intercellular Adhesion Molecule 1
10%
Minimally Invasive Surgery
10%
Digestive System
10%
Squamous Cell Carcinoma
10%
Ascending Colon
10%
Clinical Study
10%
Colectomy
10%
Pancreas Cancer
10%
Peritoneum Metastasis
10%
Estrogen Receptor
10%
Preoperative Chemotherapy
8%
CA19-9
8%
Folinic Acid
8%
Estrogen Sulfotransferase
7%
Pelvis Abscess
7%
Recurrence Free Survival
7%
Rectum Tumor
6%
Rectum Mucosa
6%
Keyphrases
Tumor
30%
Chemoradiotherapy
20%
Anal Squamous Cell Carcinoma
20%
Adjacent Organ
20%
R0 Surgery
20%
Curative Surgery
17%
Rectum
15%
Treatment Outcome
15%
Carcinoid Tumor
14%
Preoperative Chemotherapy
13%
Colorectal Cancer
12%
Rectal Carcinoma
12%
Rectal Carcinoid Tumor
10%
Human Breast Cancer Cells
10%
Estrogen Receptor 1 (ESR1)
10%
Porcine Endogenous Retrovirus
10%
Male Sexual Function
10%
Lateral Node Dissection
10%
Epithelial Cyst
10%
HMGA1
10%
Transanal Surgery
10%
Retractor
10%
Adrenal Gland Tumor
10%
Document Similarity
10%
Biomedical Literature Search
10%
Sulfamate
10%
Curated Database
10%
Similarity Detection
10%
Liver Perfusion
10%
Ex Vivo Liver Perfusion
10%
Loop Stoma
10%
Colostomy Prolapse
10%
Loop Colostomy
10%
Early Rectal Cancer
10%
Hepatic Non-parenchymal Cells
10%
Sigmoid Colon Tumor
10%
Humanized Liver
10%
Stomal Prolapse
10%
Upper Rectum
10%
Benign Breast Disease
10%
Lymph Node Metastasis
10%
Estrogen Depletion
10%
Tissue Expander
10%
Vertical Division
10%
Endostapler
10%
Tissue Correlation
10%
Infusion Chemotherapy
10%
Double Stapling Technique
10%
Mucosal Bridge
10%
Endocrine Therapy
10%
Screen-detected
10%
ZR-75-1
10%
Low Rectum
10%
Breast Reshaping
10%
Radicality
10%
Rectal Excision
10%
Borderline Phyllodes Tumor
10%
Local Flap
10%
Partial Mastectomy
10%
Oncoplastic Breast Surgery
10%
Autonomic Nerve
10%
Allelotyping
10%
Recurrent Cancer
10%
Hepatic Organoids
10%
Human Breast Carcinoma
10%
Androstenone
10%
Diols
10%
Aromatase Inhibitors
10%
Tin Colloid
10%
Everolimus
10%
Safety Considerations
10%
Sentinel Node Navigation Surgery
10%
Radiation Safety
10%
Exfoliated Cells
10%
Rectal Washout
10%
Minimally Invasive
10%
Estrone Sulfatase
10%
Skip Metastasis
10%
Lateral Lymph Node Metastasis
10%
Low Rectal Cancer
10%
Postoperative Follow-up
10%
Pelvic Abscess
10%
T4 Rectal Cancer
10%
Neoadjuvant Chemoradiotherapy (nCRT)
10%
Concurrent Chemoradiotherapy
10%
FOLFIRINOX
10%
Conversion Surgery
10%
Superior Mesenteric Artery
10%
Resectable Pancreatic Cancer
10%
Histological Remission
10%
Rehepatectomy
10%
Anal Canal Adenocarcinoma
10%
Radiation Therapy
10%
R0 Resection
10%
High-risk Stage II
10%
Stage II Colon Cancer
10%
Stage IV Colorectal Cancer
10%
Retrospective Analysis
10%
Clinical Outcomes
10%
Multi-institutional
10%
Pharmacology, Toxicology and Pharmaceutical Science
Recurrent Disease
74%
Neoplasm
47%
Chemotherapy
43%
Colorectal Cancer
41%
Breast Cancer
34%
Breast Carcinoma
27%
Lymph Node Metastasis
24%
Rectum Cancer
22%
Estrogen Receptor
22%
Diethylstilbestrol
20%
Chemoradiation Therapy
20%
Squamous Cell Carcinoma
20%
Liver Metastasis
20%
Peritoneum Metastasis
20%
Fluorouracil
18%
Aromatase Inhibitor
16%
Steryl Sulfatase
16%
Malignant Neoplasm
13%
Rectum Carcinoma
12%
Sigmoid Cancer
12%
Survival Rate
12%
Everolimus
11%
Hepatitis B Virus
10%
Cyclin D1
10%
Sulfamate
10%
Nude Mouse
10%
Serine
10%
Endocrine Therapy
10%
Adrenal Tumor
10%
Phosphoprotein Phosphatase 2A
10%
Prolapse
10%
Tamoxifen
10%
Liver Cell Carcinoma
10%
Androstane Derivative
10%
Collagen Sponge
10%
Pathophysiology
10%
Remission
10%
Colon Cancer
10%
Estrogen Sulfotransferase
9%
Recurrence Free Survival
7%
Atenolol Plus Chlortalidone
6%
Radiation Exposure
6%
Overall Survival
6%
Mitomycin
6%
Recurrence Risk
6%
2-Methoxyestradiol
5%
Chymotrypsin Inhibitor
5%